What's around the bend for healthcare venture capital in 2018? We talk Amazon, good and bad M&A, and hitting the investment peak.

Senior Managing Director, GE Ventures

As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

How a “sticky” consumer experience could help control the drain of high-cost chronic disease drugs.

Partner, Health and Life Sciences, Oliver Wyman

Trendspotting in unpredictable times. This infographic highlights five predictions for 2017.

Managing Partner, Americas, Oliver Wyman
Senior Vice President, Health Care Value, BCBSM

Even amidst the uncertainty of repeal and replace, we see some meaningful trends taking shape. Read our predictions for 2017.

Managing Partner, Americas, Oliver Wyman
Senior Vice President, Health Care Value, BCBSM

Insights in your inbox

Subscribe

The election results sent biopharma stock soaring. Breaking down what’s really on tap for biopharma over the next four years.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences Practice, Oliver Wyman

An insurance start-up, a venerable health system, and a new kind of payer-provider partnership.

Former Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Through this series of infographics, learn how payers, providers, and life sciences companies will be impacted by our 45th president.

Partner, Health and Life Sciences, Oliver Wyman

A new global report finds female representation is growing on financial services Boards and Executive Committees, but progress is slow.

Senior executives from all areas of healthcare have committed to work collaboratively on key issues impacting consumer value and overall industry sustainability.

Insights in your inbox

Subscribe
Load More